Abstract
One and 6 months after vaccination with hepatitis A virus vaccine (HAVRIX 720 Junior), immunologic responses (anti-hepatitis A virus >/=20 mIU/ml) in children with chronic hepatitis C infection seroprotection were 92% (23/25) and 75% (9/12) in children with chronic hepatitis B infection 87% (21/24) and 88% (15/17) and in healthy children 91% (20/22) at both times. A booster dose induced seroprotection in all children.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Case-Control Studies
-
Child
-
Child, Preschool
-
Chronic Disease
-
Cohort Studies
-
Female
-
Hepatitis A / complications
-
Hepatitis A / immunology*
-
Hepatitis A / prevention & control
-
Hepatitis A Antibodies / immunology*
-
Hepatitis A Vaccines / administration & dosage
-
Hepatitis A Vaccines / immunology*
-
Hepatitis B Antibodies / immunology
-
Hepatitis B, Chronic / immunology
-
Hepatitis B, Chronic / prevention & control
-
Hepatitis C Antibodies / immunology
-
Hepatitis C, Chronic / immunology
-
Hepatitis C, Chronic / prevention & control
-
Humans
-
Liver Cirrhosis / complications
-
Liver Cirrhosis / immunology*
-
Male
-
Prognosis
-
Reverse Transcriptase Polymerase Chain Reaction
-
Risk Assessment
-
Sensitivity and Specificity
-
Vaccines, Inactivated / administration & dosage
-
Vaccines, Inactivated / immunology
Substances
-
Hepatitis A Antibodies
-
Hepatitis A Vaccines
-
Hepatitis B Antibodies
-
Hepatitis C Antibodies
-
Vaccines, Inactivated